Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;32(1):60-6.
doi: 10.3174/ajnr.A2232. Epub 2010 Oct 21.

MR imaging texture analysis of the corpus callosum and thalamus in amnestic mild cognitive impairment and mild Alzheimer disease

Affiliations

MR imaging texture analysis of the corpus callosum and thalamus in amnestic mild cognitive impairment and mild Alzheimer disease

M S de Oliveira et al. AJNR Am J Neuroradiol. 2011 Jan.

Abstract

Background and purpose: TA is a branch of image processing that seeks to reduce image information by extracting texture descriptors from the image. TA of MR images of anatomic structures in mild AD and aMCI is not well-studied. Our objective was to attempt to find differences among patients with aMCI and mild AD and normal-aging subjects, by using TA applied to the MR images of the CC and the thalami of these groups of subjects.

Materials and methods: TA was applied to the MR images of 17 patients with aMCI, 16 patients with mild AD, and 16 normal-aging subjects. The TA approach was based on the GLCM. MR images were T1-weighted and were obtained in the sagittal and axial planes. The CC and thalami were manually segmented for each subject, and 44 texture parameters were computed for each of these structures.

Results: TA parameters showed differences among the 3 groups for the CC and thalamus. A pair-wise comparison among groups showed differences for AD-control and aMCI-AD for the CC; and for AD-control, aMCI-AD, and aMCI-control for the thalamus.

Conclusions: TA is a useful technique to aid in the detection of tissue alterations in MR images of mild AD and aMCI and has the potential to become a helpful tool in the diagnosis and understanding of these pathologies.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Boxplots for texture parameter-versus-subject groups for the CC (top row) and thalamus (bottom row), for the comparison among all the groups. X-axes show the studied groups, and y-axes show the magnitude of the texture parameter. The left column shows parameters that are differentiated well among groups, and the right column shows parameters that are not differentiated among groups. All plots correspond to distance d = 1.
Fig 2.
Fig 2.
Boxplots for texture parameter-versus-subject groups for the CC, for the pair-wise comparison between AD-control (top row) and AD-aMCI (bottom row). X-axes show the studied groups, and y-axes show the magnitude of the texture parameter. The left column shows parameters that are differentiated well among groups, and the right column shows parameters that are not differentiated among groups. All plots correspond to distance d = 1.
Fig 3.
Fig 3.
Maps of texture parameters computed by the MaZda software. Top row: MR imaging of a patient with AD (left), one with MCI (center), and a control subject (right). The middle and bottom rows show contrast and difference variance maps for these subjects respectively, computed from a GLCM with distance d = 1 pixel and direction θ = 90°. Both parameter maps show a variation in the CC gray level intensity for patients with AD and aMCI; it is brighter in the middle of this structure and darker at the sides. In patients with AD, the whole structure is brighter than that in patients with aMCI. This brightness variation does not occur for the control image. Although calculation of these maps used smaller regions than the segmented regions of interest used to compute the texture parameters shown in Tables 1–4 (see text), these maps give an idea of texture variation along the brain, showing that there are, indeed, texture differences among the AD, aMCI, and control individuals.

Similar articles

Cited by

References

    1. Wilmo A, Jonsson L, Winblad B.. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord 2006;21:175–81 - PubMed
    1. Cummings JL, Cole G.. Alzheimer disease. JAMA 2002;18:2335–38 - PubMed
    1. Winblad B, Palmer K, Kivipelto M, et al. . Mild cognitive impairment: beyond controversies, towards a consensus—report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–46 - PubMed
    1. Kelley BJ, Petersen RC.. Alzheimer's disease and mild cognitive impairment. Neurologic Clinics 2007;25:577–609 - PMC - PubMed
    1. Fleisher AS, Sun S, Ward CP, et al. . Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment. Neurology 2008;70:191–99 - PubMed

MeSH terms